| Financial Year |
March 31 2023 |
| Monetary Funds |
4,282,569,381.45 |
| Held-for-trading Financial Assets |
33,885,224.26 |
| Notes Receivable |
63,933,644.35 |
| Accounts Receivable |
263,903,453.95 |
| Advances to Suppliers |
86,746,029.60 |
| Other Receivables |
2,111,680,165.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
102,911,264.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
22,193,554.37 |
| Other Current Assets |
43,419,801.10 |
| Total Current Assets |
7,034,839,895.96 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
30,726,612.42 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
24,718,953.02 |
| Under-construction Projects |
17,578,634.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,157,915.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
106,176,680.80 |
| Other Non-Current Assets |
13,019,780.00 |
| Sub-Total of Non-Current Assets |
382,697,616.82 |
| Total Assets |
7,417,537,512.78 |
| Short-Term Loans |
2,778,126,110.04 |
| Trading Financial liabilities |
20,247,651.17 |
| Notes Payable |
-- |
| Accounts Payable |
70,496,938.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,138,774.59 |
| Taxes Payable |
48,383,365.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,863,724,499.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,650,546.28 |
| Other Current Liabilities |
1,172,632,420.19 |
| Sub-Total of Current Liabilities |
6,016,900,027.79 |
| Long-term Loans |
1,619,206.04 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,170,061.56 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,311,541.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,645,609.08 |
| Total Liabilities |
6,049,545,636.87 |
| Paid-In Capital(Or Share Stock) |
373,318,054.00 |
| Capital Surplus |
255,077,381.60 |
| Surplus Reserve |
83,920,878.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
655,788,559.56 |
| Minority Stockholder's Interest |
3,636,886.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,364,354,988.95 |
| Owner's Equity（Stockholder's Equity） |
1,367,991,875.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,417,537,512.78 |
